Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study
- Resource Type
- Article
- Authors
- Bar, Noffar; Mateos, Maria Victoria; Ribas, Paz; Hansson, Markus; Paris, Laura; Hofmeister, Craig C.; Rodriguez Otero, Paula; Bermúdez, Maria Aranzazu; Martin, Thomas; Santoro, Armando; Yee, Andrew J.; Creignou, Maria; Encinas Rodriguez, Cristina; Cerchione, Claudio; De La Rubia, Javier; Oriol, Albert; Waibel, Heidi; Besemer, Britta; Thompson, Ethan; Kiesel, Brian; Chen, Jinjie; Chung, Alexander; Boss, Isaac W.; Gaudy, Allison; Li, Shaoyi; Hsu, Kevin; Godwin, Colin; Burgess, Michael R.; San-Miguel, Jesús; Costa, Luciano
- Source
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p2011-2011, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020